The leiomyosarcoma treatment market is estimated to be valued at USD 1.3 billion in 2024 and is expected to reach USD 2.4 billion by 2031, growing at a compound annual growth rate (CAGR) of 9% from 2024 to 2031. https://www.zupyak.com/p/4474276/t/the-growing-demand-for-targeted-therapies-in-the-leiomyosarcoma-market